Global Cancer Biomarkers Market 2012-2016


January 11, 2013
37 Pages - SKU: INF4944581
License type:
Countries covered: Global

TechNavio's analysts forecast the Global Cancer Biomarkers market to grow at a CAGR of 18.22 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of cancer. The Global Cancer Biomarkers market has also been witnessing the trend of the emergence of personalized medicines. However, the poor regulatory and reimbursement systems could pose a challenge to the growth of this market.

TechNavio's report, the Global Cancer Biomarkers market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Cancer Biomarkers market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this market space are Abbott Laboratories, Affymetrix, Inc., Agilent Technologies Inc., Gen-Probe Inc., Hologic, Inc., and Roche Diagnostics Corp.The other vendors mentioned in the report are Agendia BV, Ambrilia Biopharma, Astellas Pharma US Inc., Morphotek, Inc., Gen-Probe, Inc., Veridex LLC, Morphotek, Inc., Immunomedics, Inc., Clarient, Inc.

Key questions answered in this report:
  • What will the market size be in 2016 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
TechNavio's research portfolio in the Healthcare series includes reports on the Pharmaceutical Market, Medical Devices Market, Diagnostic Market, Vaccine Market, Oncology Market, CRO Market, Orthopedic Market, Hearing Aids Market, Dental Care Market, Medical Imaging Market, Endoscopy Market, Dialysis Market, Telemedicine Market, Cancer Drug Market, Glucose Monitoring Market, Infusion Pumps Market, Defibrillators Market, Neuromodulation Market, Capnography Market.



More Oncology/Hematology reports by Infiniti Research Limited

Global Leukemia Therapeutics Market 2012-2016 by Infiniti Research Limited
TechNavio's analysts forecast the Global Leukemia Therapeutics market to grow at a CAGR of 10 percent over the period 2012-2016. One of the key factors ...
Global Kidney Cancer Drugs Market 2012-2016 by Infiniti Research Limited
TechNavio's analysts forecast the Global Kidney Cancer Drugs market to grow at a CAGR of 13.4 percent over the period 2012-2016. One of the key ...
Global Next Generation Cancer Diagnostic Devices Market 2012-2016 by Infiniti Research Limited
TechNavio's analysts forecast the Global Next-generation Cancer Diagnostic Devices market to grow at a CAGR of 48.11 percent over the period 2012-2016. One of the ...
Global Lung Cancer Therapeutics Market 2012-2016 by Infiniti Research Limited
TechNavio's analysts forecast the Global Lung Cancer Therapeutics market to grow at a CAGR of 13.26 percent over the period 2012-2016. One of the key ...
See all reports like this >>

More Global Oncology/Hematology reports

The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives by Kalorama Information
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives Cancer testing is maturing from personalized medicine to precision medicine, where ...
Cancer Pain Global Clinical Trials Review, H1, 2013 by GlobalData
Cancer Pain Global Clinical Trials Review, H1, 2013SummaryGlobalData's clinical trial report, “Cancer Pain Global Clinical Trials Review, H1, 2013 provides data on the Cancer Pain ...
Global Leukemia Therapeutics Market 2012-2016 by Infiniti Research Limited
TechNavio's analysts forecast the Global Leukemia Therapeutics market to grow at a CAGR of 10 percent over the period 2012-2016. One of the key factors ...
Global Kidney Cancer Drugs Market 2012-2016 by Infiniti Research Limited
TechNavio's analysts forecast the Global Kidney Cancer Drugs market to grow at a CAGR of 13.4 percent over the period 2012-2016. One of the key ...
See all reports like this >>

 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!